Long-term survival, clinical activity, and safety of nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in patients (Pts) with advanced non-small cell lung cancer (NSCLC): Metastatic non-small cell lung cancer Meeting Abstract

  

Authors:	Gettinger, S. N.; Horn, L.; Gandhi, L.; Spigel, D. R.; Antonia, S. J.; Rizvi, N. A.; Powderly, J. D.; Heist, R. S.; Carvajal, R. D.; Jackman, D. M.; Sequist, L. V.; Smith, D. C.; Leming, P. D.; Topalian, S. L.; Hodi, F.; Sznol, M.; Harbison, C. T.; Kollia, G. D.; Brahmer, J. R.
Abstract Title:	Long-term survival, clinical activity, and safety of nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in patients (Pts) with advanced non-small cell lung cancer (NSCLC): Metastatic non-small cell lung cancer
Meeting Title:	2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Journal Title:	International Journal of Radiation Oncology, Biology, Physics
Volume:	90
Issue:	5 Suppl.
Meeting Dates:	2014 Oct 30-Nov 1
Meeting Location:	Chicago, IL
ISSN:	0360-3016
Publisher:	Elsevier Inc.
Date Published:	2014-11-15
Start Page:	S34
Language:	English
ACCESSION:	WOS:000346413500072
PROVIDER:	wos
DOI:	10.1016/j.ijrobp.2014.08.209
Notes:	Meeting Abstract: 170 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/67501